Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Supply Chain
May 30, 2023 05:00 AM

Coming up short: Why drug shortages are occurring

Alex Kacik
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Copy of supply chain_i.jpg

    Healthcare providers are grappling with a shortage of chemotherapy drugs, leading to dose rationing and delayed care.

    Supply chain managers have seen similar supply issues with cisplatin and other chemotherapy treatments in year’s past, and the supply-demand imbalance for many medications is likely to continue.

    Never miss an important news story again. Sign up for Modern Healthcare Alerts.

    “It feels a little like Groundhog Day,” said Erin Fox, senior pharmacy director at University of Utah Health, noting similar issues with chemo drugs in 2011. “We are not seeing progress because we haven’t done the work to incentivize quality.”

    It's not just chemo medications. Health system administrators and clinicians constantly manage a rotating list of dozens of pharmaceuticals in short supply. Providers are often forced to conserve drugs that are used daily in hospitals and find alternative suppliers or substitute medication, a practice that could jeopardize patient safety, limit access to care and squeeze hospital margins.

    Here is what you need to know about drug shortages and how they affect care.

    Why some drugs are regularly hard to find

    Manufacturing quality issues and financial considerations drive many shortages. There are often one or two main suppliers of certain dosages of sterile injectable drugs like epinephrine, which is used to treat severe allergic reactions, and saline, which is used to deliver intravenous medications and stabilize patients during surgery. These drugs require specialized production for relatively inexpensive products. Many manufacturers divert resources to higher-margin items as a result. 

    Related: Home cancer treatment faces challenges post-pandemic

    In May, drug manufacturer Teva said it will “pivot to growth” by focusing on “high-value” drugs, consolidating its manufacturing network and trimming some low-margin generics. Akorn Pharmaceuticals, the sole manufacturer of a large dose of the asthma treatment albuterol, has stopped production of multiple generic products as it sells assets through it Chapter 7 bankruptcy. When one production line at a major facility stops, either temporarily or permanently, it can send a ripple effect through the entire industry as smaller manufacturers struggle to plug the supply gap.

    “If a manufacturer gets undercut through some sort of bidding process or they run into a quality roadblock, they may decide it’s not worth continuing," said Michael Ganio, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists.

    Unanticipated demand spikes, like those experienced during the COVID-19 pandemic when the surge of ventilated patients strained the supply of asthma drugs and sedatives, can also spur shortages. The pandemic has had a lingering effect on pharmaceutical ingredient producers, many of which are in China and India and have had trouble keeping up with demand amid staffing issues.

    “Many of these products have stable demand forecasts, so they keep inventory low to protect their margins,” said David Dobrzykowski, an associate professor of supply chain management at the University of Arkansas and director of the university's Walton College Healthcare Initiatives. “As soon as you have a disruption, there isn’t as much safety stock around and it’s hard to ramp up manufacturing quickly.”

    How health systems manage shortages

    Many health system supply chain managers have daily huddles with clinicians and administrators as they review products in short supply and potential substitutes.

    St. Louis-based SSM Health has organized a centralized drug shortage team that coordinates pharmaceutical inventories and sourcing strategies across its 23 hospitals. The team reallocates inventory across its hospital network, surveys alternative suppliers and reviews conservation strategies when supplies are low, said Michelle Schmitt, director of pharmacy business operations at SSM.

    Related: Proposed EPA rule prompts concern over device shortages

    Health systems often have long-term, bulk purchasing deals with manufacturers or wholesalers for widely used drugs. That means they can rely on a consistent volume from a certain supplier at a stable price. But when they are forced to source alternative suppliers and products, they often have to enter into one-time purchasing agreements. They not only pay a premium, but often have to spend time training clinicians on how and when to administer an unfamiliar product.

    How the drug supply chain works

    The pharmaceutical supply chain is obfuscated by a web of suppliers, subcontractors and middlemen. Many large manufacturers use subcontractors, and there is minimal insight into their production capacity. Manufacturers are not required to publicly provide specific reasons for shortages, leaving most health systems in the dark.

    Despite pushes from advocacy groups and pleas to Congress, there isn’t any transparency on which suppliers are more reliable and proficient, Fox said. Still, increasing transparency doesn’t address the core problem: a lack of supply of critical, widely used drugs. 

    Related: Healthcare supply chain grapples with wide range of shortages

    Manufacturers distribute drugs to wholesalers and group purchasing organizations, and sometimes directly to pharmacies or hospitals. Some GPOs have created private drug labels in which they contract directly with a manufacturer to make a generic drug under their own brand name.

    On behalf of health plans and employers, pharmacy benefit managers negotiate rebates and other discounts with manufacturers. PBMs and payers design the formulary, which is a list of drugs that are covered under the health plan. Patients pay less when a drug is placed on a higher formulary tier.

    Why shortages squeeze margins

    When demand spikes and supply wanes, prices go up. Hospitals typically don't have the flexibility to renegotiate reimbursement with insurers in real time, and with Medicare and Medicaid paying fixed rates, they often have to assume the higher costs. In some cases, Medicare offers temporary reimbursement boosts for hospital-owned outpatient departments known as "pass-through payments," which are designed to offset the cost of innovative, high-priced therapies. 

    Dueling Opinions: Grappling with new supply chain bottlenecks

    Delaying care also dents revenue. If hospitals don't have saline to stabilize patients during surgery, they may have to postpone elective procedures, which are high revenue generators. Providers may also have to prioritize doses for the most critical patients, leaving some patients in the lurch. When chemotherapy drugs were short in 2011, healthcare organizations paused clinical trials, potentially postponing breakthrough treatments.  

    How drug shortages could get fixed

    Industry experts have proposed a number of solutions designed to shore up the drug supply chain, ranging from increasing U.S. production to rewarding high-quality manufacturers.

    Bringing more production to the U.S. often requires health systems to pay a premium for products produced in this country., which they have been reluctant to do.

    Civica, a health system-backed generic drug company, is building a 120,000-square-foot sterile injectable manufacturing facility in Petersburg, Virginia. Civica has primarily subcontracted with manufacturers, getting hospitals to guarantee to buy a certain percentage of their total volume for a specific drug over a long-term, fixed-rate contract. The reliability of the allotment guarantees and fixed prices help health systems manage costs, particularly when prices spike during shortages. 

    In March, Fox and other industry experts recommended to a Senate Homeland Security and Governmental Affairs subcommittee that Congress implement a rating system for pharmaceutical manufacturers. The Centers for Medicare and Medicaid Services could give hospitals an add-on payment when they purchase high-quality drugs, she said. The federal government could also give manufacturers interest-free loans or other subsidies for improving their manufacturing facilities or producing critical drugs, Fox said.

    Related Articles
    Persistent sterile injectable drugs shortages put patients at risk
    Hospitals grapple with saline shortages
    Civica Rx aims to stabilize fragile pharmaceutical supply chain
    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Dollar sign money
    KKR takes strategic stake in medical supplier Henry Schein
    UPS
    How healthcare became UPS’ $20B lifeline
    Most Popular
    1
    Here are new state healthcare laws taking effect in 2025
    2
    Meet Modern Healthcare's 2025 Leading Women
    3
    New York-Presbyterian layoffs affect 2% of employees
    4
    Evernorth, Optum, CenterWell units buoyed insurers in Q1
    5
    Epic CEO Judy Faulkner on AI, antitrust and consolidation
    Sponsored Content
    Daily Dose Newsletter: Sign up to receive a late afternoon weekday roundup of that day’s breaking news and developments in healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content